Cita APA (7a ed.)

Romito, I., Porru, M., Braghini, M. R., Pompili, L., Panera, N., Crudele, A., . . . Alisi, A. (2021). Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects. BMC.

Cita Chicago Style (17a ed.)

Romito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.

Cita MLA (8a ed.)

Romito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.